News Feed

A new study has raised intriguing questions about why some healthy young non-smokers develop lung cancer. Researchers observed that participants with healthier diets unexpectedly showed higher rates of the disease, prompting investigations into whether pesticide exposure from conventionally grown fruits and vegetables could be a contributing factor. However, the researchers emphasize that these findings are preliminary and do not prove that pesticides cause lung cancer. Many other factors could explain the association, and further large-scale studies are needed before drawing conclusions. The research highlights the importance of continued investigation into the causes of lung cancer in non-smokers.

A new study has revealed that exercise does more than strengthen the heart—it also reshapes the nerves that control its function. Researchers found that physical activity can rewire the heart's nerve network, improving the way it regulates heartbeat and responds to stress. This discovery offers fresh insight into why regular exercise protects cardiovascular health and may open the door to more personalized treatments for common heart conditions such as arrhythmias and angina. By understanding how exercise influences both the heart muscle and its nervous system, scientists hope to develop new therapies that mimic these protective effects for patients unable to exercise regularly.

Scientists are advancing research on extracellular vesicles (EVs), tiny nanoparticles naturally released by cells that carry biological information throughout the body. These microscopic "messengers" could one day deliver drugs, repair damaged tissues, regulate inflammation, and support gene therapies with greater precision than current treatments. Researchers have also identified a new manufacturing approach using nuclear magnetic resonance (NMR) technology to improve the large-scale production of EV-based therapies. Although these treatments are still in development, the findings bring regenerative medicine a step closer to creating safer, more targeted therapies for conditions such as cancer, heart disease, and immune-related disorders.

Updated menopause guidance is helping women make more informed decisions about hormone replacement therapy (HRT), following years of confusion after early studies raised concerns about its risks. Experts now emphasize that HRT is generally most effective and safest when started before age 60 or within 10 years of menopause for women with bothersome symptoms. When tailored to an individual's health profile, HRT can reduce hot flashes, improve sleep, support bone health, and enhance quality of life. The latest recommendations encourage personalized care, regular reassessment, and open discussions between women and healthcare providers to ensure the benefits outweigh potential risks.

A new preclinical study suggests that blocking the protein menin could become a powerful treatment for myeloproliferative neoplasms (MPNs), a group of rare blood cancers. Researchers found that the FDA-approved menin inhibitor revumenib significantly extended survival, prevented bone marrow fibrosis, and restored normal blood cell counts in preclinical models. Unlike previous approaches, menin inhibition targeted the disease at its source by eliminating early cancer-forming cells rather than later-stage cells. Since revumenib is already approved for certain types of leukemia, these findings could accelerate clinical trials to evaluate its potential as a new treatment option for patients with MPNs.

Researchers have discovered that a simple, non-invasive low-intensity ultrasound treatment may help prevent arthritis by promoting healthier joint healing after injury. In the study, continuous ultrasound encouraged macrophages—immune cells that regulate inflammation—to switch from a damaging inflammatory state to one that supports tissue repair. This shift could help injured joints recover more effectively instead of remaining trapped in chronic inflammation, a major driver of arthritis. Although more research is needed before the approach reaches clinical use, the findings highlight a promising, drug-free strategy for reducing the risk of arthritis and improving long-term joint health.

A new study has revealed that the tau protein, best known for its role in Alzheimer's disease, is also essential for forming long-term memories. In mouse experiments, researchers found that tau helps organize the brain's memory-storing cells, allowing new experiences to be converted into lasting memories. The findings suggest that healthy tau is crucial for normal brain function, while abnormal tau may interfere with both the creation of new memories and the recall of existing ones. This discovery provides fresh insight into how Alzheimer's disease develops and could guide future therapies aimed at preserving memory and slowing cognitive decline.

Researchers have developed an innovative approach that uses the natural behavior of Escherichia coli (E. coli) to predict whether a COVID-19 patient is likely to develop a mild or severe form of the disease. Instead of genetically modifying the bacteria, scientists exposed them to patients' blood plasma and analyzed their growth patterns, which reflected the plasma's chemical composition. This living "biosensor" successfully distinguished between mild and severe cases without using traditional machine-learning models. The low-cost technique could pave the way for affordable diagnostic and prognostic tools for COVID-19 and other diseases, while also offering future applications in environmental monitoring and wastewater analysis.

Researchers have uncovered previously unknown changes in blood vessels that may explain why certain oral inflammatory diseases, such as peri-implantitis and rapidly advancing periodontitis, cause rapid tissue destruction. Using the Human Periodontal Atlas, the team identified increased levels of the inflammatory protein CD38 in blood vessel cells, suggesting a shared mechanism that could become a future drug target. The findings not only improve understanding of severe gum disease but also offer valuable insights into other inflammatory conditions, including cancer. Researchers now plan to expand their single-cell atlases across more than 20 diseases to identify common disease pathways and develop more targeted therapies.

The American Gastroenterological Association (AGA) has introduced Nigel, an AI-powered virtual assistant designed specifically for gastroenterology and hepatology clinicians. Unlike general AI tools, Nigel is built on AGA's peer-reviewed clinical guidelines and the GRADE evidence framework, providing fast, transparent, and evidence-based answers at the point of care. The assistant helps doctors interpret guidelines, validate diagnostic and treatment decisions, and access the latest research within seconds. With its knowledge base updated in real time as new clinical guidance emerges, Nigel aims to reduce time spent searching for information, ease clinician workload, and ultimately improve patient care.